Hamid Mollazadeh

2.6k total citations · 1 hit paper
49 papers, 2.0k citations indexed

About

Hamid Mollazadeh is a scholar working on Molecular Biology, Complementary and alternative medicine and Pharmacology. According to data from OpenAlex, Hamid Mollazadeh has authored 49 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 12 papers in Complementary and alternative medicine and 10 papers in Pharmacology. Recurrent topics in Hamid Mollazadeh's work include Glioma Diagnosis and Treatment (5 papers), Nigella sativa pharmacological applications (5 papers) and Medicinal Plants and Neuroprotection (4 papers). Hamid Mollazadeh is often cited by papers focused on Glioma Diagnosis and Treatment (5 papers), Nigella sativa pharmacological applications (5 papers) and Medicinal Plants and Neuroprotection (4 papers). Hamid Mollazadeh collaborates with scholars based in Iran, United States and Italy. Hamid Mollazadeh's co-authors include Amirhossein Sahebkar, Amir R. Afshari, Hossein Hosseinzadeh, Matteo Pirro, Christopher N. Blesso, Hamid Reza Sadeghnia, Muhammed Majeed, Arrigo F.G. Cicero, Mohammad Jalili‐Nik and Tannaz Jamialahmadi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Critical Reviews in Food Science and Nutrition and Journal of Cellular Physiology.

In The Last Decade

Hamid Mollazadeh

47 papers receiving 2.0k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effects of statins on mitochondrial pathways

2021 167 citations Hamid Mollazadeh, Tannaz Jamialahmadi et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hamid Mollazadeh Iran	26	663	362	266	254	217	49	2.0k
Osman Çiftçi Türkiye	27	412 0.6×	249 0.7×	235 0.9×	223 0.9×	333 1.5×	108	2.1k
Chi Teng Vong Macao	25	1.0k 1.6×	309 0.9×	306 1.2×	230 0.9×	195 0.9×	55	2.2k
Chunhua Ma China	28	1.2k 1.8×	268 0.7×	339 1.3×	264 1.0×	209 1.0×	56	2.3k
Somasundaram Arumugam Japan	32	1.0k 1.5×	179 0.5×	249 0.9×	176 0.7×	202 0.9×	86	2.8k
El‐Shaimaa A. Arafa Egypt	25	789 1.2×	266 0.7×	275 1.0×	156 0.6×	261 1.2×	63	2.1k
Bidya Dhar Sahu India	26	745 1.1×	203 0.6×	291 1.1×	248 1.0×	215 1.0×	58	2.1k
Esrafil Mansouri Iran	26	522 0.8×	153 0.4×	224 0.8×	127 0.5×	252 1.2×	92	1.8k
Jingyuan Wan China	38	1.3k 2.0×	419 1.2×	636 2.4×	353 1.4×	350 1.6×	112	3.5k
Pabitra Bikash Pal India	15	844 1.3×	216 0.6×	193 0.7×	134 0.5×	171 0.8×	17	2.1k
Jagriti Bhatia India	33	942 1.4×	592 1.6×	415 1.6×	315 1.2×	361 1.7×	93	3.0k

Countries citing papers authored by Hamid Mollazadeh

Since Specialization

Citations

This map shows the geographic impact of Hamid Mollazadeh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hamid Mollazadeh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hamid Mollazadeh more than expected).

Fields of papers citing papers by Hamid Mollazadeh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hamid Mollazadeh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hamid Mollazadeh. The network helps show where Hamid Mollazadeh may publish in the future.

Co-authorship network of co-authors of Hamid Mollazadeh

This figure shows the co-authorship network connecting the top 25 collaborators of Hamid Mollazadeh. A scholar is included among the top collaborators of Hamid Mollazadeh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hamid Mollazadeh. Hamid Mollazadeh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Afshari, Amir R., Mehdi Sanati, Hamid Mollazadeh, et al.. (2022). Nanoparticle-based drug delivery systems in cancer: A focus on inflammatory pathways. Seminars in Cancer Biology. 86(Pt 2). 860–872. 56 indexed citations

Afshari, Amir R., Mehdi Sanati, Samaneh Aminyavari, et al.. (2022). Advantages and drawbacks of dexamethasone in glioblastoma multiforme. Critical Reviews in Oncology/Hematology. 172. 103625–103625. 28 indexed citations

Sanati, Mehdi, Maryam Moradi Binabaj, Samaneh Aminyavari, et al.. (2022). Recent advances in glioblastoma multiforme therapy: A focus on autophagy regulation. Biomedicine & Pharmacotherapy. 155. 113740–113740. 23 indexed citations

Mollazadeh, Hamid, et al.. (2021). Nicolau syndrome: a review of case studies. Pharmaceutical Sciences. 5 indexed citations

Afshari, Amir R., Arash Soltani, Hossein Javid, et al.. (2021). Neurokinin-1 Receptor (NK-1R) Antagonists: Potential Targets in the Treatment of Glioblastoma Multiforme. Current Medicinal Chemistry. 28(24). 4877–4892. 24 indexed citations

Jalili‐Nik, Mohammad, Hamid Mollazadeh, Bahram Bibak, et al.. (2021). Targeting the PD-1/PD-L1 pathway in glioblastoma multiforme: Preclinical evidence and clinical interventions. International Immunopharmacology. 93. 107403–107403. 42 indexed citations

Mohtashami, Elmira, Hamid Mollazadeh, Seyed Hadi Mousavi, et al.. (2020). The Current State of Potential Therapeutic Modalities for Glioblastoma Multiforme: A Clinical Review. Current Drug Metabolism. 21(8). 564–578. 23 indexed citations

Mollazadeh, Hamid, Elmira Mohtashami, Mohammad Soukhtanloo, et al.. (2020). Deciphering the Role of Glutamate Signaling in Glioblastoma Multiforme: Current Therapeutic Modalities and Future Directions. Current Pharmaceutical Design. 26(37). 4777–4788. 15 indexed citations

Afshari, Amir R., Hamid Mollazadeh, Elmira Mohtashami, et al.. (2020). Protective Role of Natural Products in Glioblastoma Multiforme: A Focus on Nitric Oxide Pathway. Current Medicinal Chemistry. 28(2). 377–400. 34 indexed citations

10.

Afshari, Amir R., et al.. (2020). Effects of statins on brain tumors: a review. Seminars in Cancer Biology. 73. 116–133. 61 indexed citations

11.

Boroushaki, Mohammad Taher, et al.. (2019). Reno-protective effect of Rheum turkestanicum against gentamicin-induced nephrotoxicity. SHILAP Revista de lepidopterología. 16 indexed citations

12.

Mollazadeh, Hamid, et al.. (2018). Medicinal plants in treatment of hypertriglyceridemia: A review based on their mechanisms and effectiveness. Phytomedicine. 53. 43–52. 45 indexed citations

13.

Mollazadeh, Hamid, Stephen L. Atkin, Alexandra E. Butler, et al.. (2018). The effect of statin therapy on endoplasmic reticulum stress. Pharmacological Research. 137. 150–158. 35 indexed citations

14.

Boroushaki, Mohammad Taher, et al.. (2018). Protective effect of Rheum turkestanicum against cisplatin by reducing oxidative stress in kidney tissue. Journal of Pharmacy And Bioallied Sciences. 10(2). 66–66. 12 indexed citations

15.

Keshavarzi, Zakieh, et al.. (2017). Traumatic Brain Injury and the Gastrointestinal Tract: The Role of Female Sexual Hormones. Journal of Endocrinology and Metabolism. 7(6). 163–171.

16.

Mollazadeh, Hamid, Mohammad Taher Boroushaki, Mohammad Soukhtanloo, Amir R. Afshari, & Mohammad Mahdi Vahedi. (2017). Effects of pomegranate seed oil on oxidant/antioxidant balance in heart and kidney homogenates and mitochondria of diabetic rats and high glucose-treated H9c2 cell line.. SHILAP Revista de lepidopterología. 7(4). 317–333. 13 indexed citations

17.

Shafiee-Nick, Reza, Amir R. Afshari, Seyed Hadi Mousavi, et al.. (2017). A comprehensive review on the potential therapeutic benefits of phosphodiesterase inhibitors on cardiovascular diseases. Biomedicine & Pharmacotherapy. 94. 541–556. 38 indexed citations

18.

Hosseini, Azar, Hamid Mollazadeh, Mohammad Sadegh Amiri, Hamid Reza Sadeghnia, & Ahmad Ghorbani. (2016). Effects of a standardized extract of Rheum turkestanicum Janischew root on diabetic changes in the kidney, liver and heart of streptozotocin-induced diabetic rats. Biomedicine & Pharmacotherapy. 86. 605–611. 59 indexed citations

19.

Mollazadeh, Hamid, et al.. (2016). Effects of pomegranate seed oil on oxidative stress markers, serum biochemical parameters and pathological findings in kidney and heart of streptozotocin-induced diabetic rats. Renal Failure. 38(8). 1256–1266. 44 indexed citations

20.

Boroushaki, Mohammad Taher, et al.. (2014). Protective effect of pomegranate seed oil against mercuric chloride-induced nephrotoxicity in rat. Renal Failure. 36(10). 1581–1586. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact